...SUBCHAPTER H: MEDICAL DEVICES. PART 808: EXEMPTIONS FROM FEDERAL PREEMPTION OF STATE A...(10) Part 820 of this chapter (21 CFR part 820) (CGMP requiremen...
... can comment on any guidance at any time (see 21 CFR 10.115(g)(5)), to ensure that the Agency consi...Registration and listing (21 CFR part 807); labeling (21 CFR part 801 and 21 CFR 809.10)... in the Quality System regulation (21 CFR part 820); and Medical. Device Reporting requirements (21 C...
The Food and Drug Administration (FDA) is announcing the availability of the guidance entitled ``Enforcement Policy for Premarket Notification Requirements for Certain In Vitro Diagnostic and Radiology Devices.'' This document describes FDA's intent with regard to enforcement of premarket notification (510(k)) requirements for certain in vitro diagnostic and radiology devices under the regulations.
... limitations to the exemption criteria found in 21 CFR 862.9, 21 CFR 864.9, 21 CFR 866.9, and 21 CFR ... not limited to: Registration and listing (part 807 (21 CFR part 807)); labeling (part 801 (21 CFR... forth in the Quality System regulation (part 820 (21 CFR part 820)); and Medical Device Reporting r...
... records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(...Rubber Latex Condoms Classified Under 21 CFR 884.5300--(OMB Control. Number 0910-0633)--Ext... collections of information under 21 CFR part 820 have been approved under OMB control number 0910-0...
...10.115(g)(5) (21 CFR 10.115(g)(5))), to ensure that the Agency cons... unsafe or ineffective medical treatment is part of a process for controlling overall risk. For dev... The collections of information in 21 CFR part 820 are approved under OMB control number 0910-0073; t...
The Regulatory Flexibility Act of 1980 and Executive Order (EO) 12866 require the semiannual issuance of an inventory of rulemaking actions under development throughout the Department with a view to offering summarized information about forthcoming regulatory actions for public review.
...77. Monday,. No. 29. February 13, 2012. Part VIII. Department of Health and Human Services. ---...Office of the Secretary. 21 CFR Ch. I. 42 CFR Chs. I-V. 45 CFR Subtitle A; Sub... the Quality Systems Regulation in 21 CFR part 820) to identify differences and consider the value of...
The Food and Drug Administration (FDA) is announcing the availability of the draft guidance document entitled ``Draft Guidance for Industry and FDA Staff: The Content of Investigational Device Exemption (IDE) and Premarket Approval (PMA) Applications for Artificial Pancreas Device Systems.'' This draft guidance document provides industry and the Agency staff with guidelines for developing premarket submissions for artificial pancreas device systems, in particular, the Control-to-Range (CTR) and Control-to-Target (CTT) device systems. This draft guidance is not final nor is it in effect at this time.
... can comment on any guidance at any time (see 21 CFR 10.115(g)(5)), to ensure that the Agency consi... the collections of information in 21 CFR part 820 are approved under OMB control number 0910-0073. V...
...I. Background. Section 564 of the act (21 U.S.C. 360bbb-3), as amended by the. Project BioSh... the quality system requirements under 21 CFR Part 820 with respect to the design, manufacture, packa...
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995 (the PRA).
... Natural Rubber Latex Condoms Classified Under 21 CFR 884.5300--(OMB Control Number 0910-0633)--Exte... market yearly and collectively have a third-party disclosure burden of 1,224 hours. The number of re... collections of information under 21 CFR part 820 have been approved under OMB control number 0910-0...
The Food and Drug Administration (FDA) is announcing the availability of a draft guidance entitled ``Class II Special Controls Guidance Document: Nucleic Acid-Based In Vitro Diagnostic Devices for the Detection of Mycobacterium tuberculosis Complex in Respiratory Specimens.'' This document was developed to support the reclassification of nucleic acid-based in vitro diagnostic devices for the detection of M. tuberculosis complex in respiratory specimens from class III into class II. These devices are intended to be used as an aid in the diagnosis of pulmonary tuberculosis. This draft guidance document describes a means by which in vitro diagnostic devices for the detection of M. tuberculosis complex in respiratory specimens may comply with the requirement of special controls for class II...
...Vol. 77. Monday,. No. 53. March 19, 2012. Part II. Department of Health and Human Services. -----...21 CFR Part 866. Draft Guidance for Industry and Food...
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United States
Explore vLex
For Professionals
For Partners
Company
Other interesting searches:
processed food production | John Coyne | amortization negative regulations | miranda rights amendments | Cuvee Napa | machefer | documento programmatico sicurezza | control de constitucionalidad europeo | Daños in contrahendo | Craon
